Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2018; 14(04): 300DOI: 10.1055/a-0752-6656 Studienreferate Georg Thieme Verlag KG Stuttgart · New York Kommentar Recommend Article Abstract Buy Article All articles of this category Comment on: Ergebnisse einer „Watch-and-wait“-Strategie bei Patienten mit RektumkarzinomGastroenterologie up2date 2018; 14(04): 299-300DOI: 10.1055/a-0752-6564 Full Text References Literatur 1 Martens MH, Maas M, Heijnen LA. et al. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer. J Natl Cancer Inst 2016; 108 2 Schmiegel W, Buchberger B, Follmann M. et al. S3-Leitlinie – Kolorektales Karzinom. Z Gastroenterol 2017; 55: 1344-1498 doi:10.1055/s-0043-121106 3 Rullier E, Rouanet P, Tuech JJ. et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet 2017; 390: 469-479 doi:10.1016/S0140-6736(17)31056-5 4 Appelt AL, Pløen J, Harling H. et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 2015; 16: 919-927 doi:10.1016/S1470-2045(15)00120-5
